Targeting One

About:

Targeting One is an in-vitro diagnostic product developer.

Website: http://www.targetingone.com

Top Investors: Hillhouse Investment, Lilly Asia Ventures, Jiuzhi Ziben, China Growth Capital | CGC, Wonderland Capital

Description:

Targeting One is a joint-stock technology firm that creates reagents, software, and other products. It is committed to developing products in the life science and molecular diagnostic enterprise, serving life science, precision medicine, drug development, and health management, by developing molecular diagnostic technologies with multiple indicators, high throughput, automation, pollution prevention, and relatively inexpensive.

Total Funding Amount:

250M CNY

Headquarters Location:

Haidian, Beijing, China

Founded Date:

2015-01-01

Contact Email:

info(AT)targetingone.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-02-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai